Simultaneous determination of MAO-A and -B activity following first time intake of an irreversible MAO-B inhibitor in patients with Parkinson’s disease
Crossref DOI link: https://doi.org/10.1007/s00702-017-1705-z
Published Online: 2017-03-15
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Müller, Thomas
Riederer, Peter
Grünblatt, Edna
Funding for this research was provided by:
Verin für Neurowissenschaftliche Tagungen
License valid from 2017-03-15